Review article · 16 Jul 2016
Conference abstractPublished 19 Dec 2014
Continuous process improvement in vaccine delivery
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vaccines are one of the greatest achievements in public health. However, critical evaluation and continuous process improvement areneeded to ensure that vaccines are stored, handled and administeredproperlyto avoid compromising the vaccine. Failure to do so will result in vaccine wastage with resultant cost implications, and may potentiallyexpose people to disease and erode confidence in vaccination. A panel of the United States immunization experts from national immunization policy organizations; state and local immunization programs; healthcare practitioners; and, members of the vaccine industry convened to identify and evaluate challenges to vaccine delivery - from storage and handling through vaccine preparation and administration. A report of the first meeting identifying issues was recently published1. The group?s primary observation was that the unrecognized complexity of vaccine delivery posed a major challenge to appropriate delivery of vaccines. Proper training, storage, cold chain maintenance, handling, preparation, administration, and documentation were areas where continuous process improvement would benefit the immunization process. A follow-upmeeting was held to discuss possible solutions to identified challenges within each area of the vaccine delivery process, with an emphasis on education, training, oversight, and technology. The overarching goal was to simplify the complex process of vaccine delivery. Top priority short-term solutions included increasing awareness about unrecognized complexity, encouraging use of existing assets like current guidance and ready-to-administer vaccines, simplifying and standardizing packaging, and utilizing the recently launched Vaccine Error Reporting Program (VERP). Longer-term solutions included national standards and minimum core competency requirements, provider incentives, and integrating improved technology.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 27 Jul 2018
Comparison of three sample size estimation methods for non-inferiority vaccine trials with multiple continuous co-primary endpoints
Short communication · 30 Jun 2020
Effect of Continuous Epidural Anaesthesia in Painless Delivery
Conference abstract · 16 Oct 2017
Ocular and plasmic dexamethasone distribution following controllable continuous subtenon drug delivery in rabbit
Conference abstract · 2017
Ocular and plasmic dexamethasone distribution following controllable continuous sub-tenon drug delivery in rabbit
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Litjen Tan”
